BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 334084)

  • 1. Cicatricial pemphigoid of Brunsting-Perry. Immunofluorescent studies.
    Michel B; Bean SF; Chorzelski T; Fedele CF
    Arch Dermatol; 1977 Oct; 113(10):1403-5. PubMed ID: 334084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cicatricial pemphigoid (Brunsting-Perry type). Case report and immunofluorescence findings.
    Jacoby WD; Bartholome CW; Ramchand SC; Simmons EB; Burnham TK
    Arch Dermatol; 1978 May; 114(5):779-81. PubMed ID: 348119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear dermo-epidermal IgA deposition in bullous pemphigoid.
    van Joost T; Faber WR; Westerhof W; de Mari F
    Acta Derm Venereol; 1979; 59(5):463-5. PubMed ID: 93374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Localized cicatricial bullous pemphigoid of the Brunsting-Perry type].
    Kurzhals G; Maciejewski W; Agathos M; Meurer M; Mily H; Breit R
    Hautarzt; 1993 Feb; 44(2):110-3. PubMed ID: 8449691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cicatricial pemphigoid with circulating antibasement membrane antibodies. Report of three atypical cases.
    Person JR; Rogers RS; Jordon RE
    Dermatologica; 1977; 154(2):90-7. PubMed ID: 323083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
    Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
    Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic bullous disease with coexistent circulating IgG and IgA anti-basement membrane zone antibodies.
    Miyagawa S; Kiriyama Y; Shirai T; Ohi H; Sakamoto K
    Arch Dermatol; 1981 Jun; 117(6):349-53. PubMed ID: 7018404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathology of cicatricial pemphigoid: studies of complement deposition.
    Rogers RS; Perry HO; Bean SF; Jordon RE
    J Invest Dermatol; 1977 Jan; 68(1):39-43. PubMed ID: 318674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized cicatricial pemphigoid (Brunsting-Perry). A transplantation experiment.
    Ahmed AR; Salm M; Larson R; Kaplan R
    Arch Dermatol; 1984 Jul; 120(7):932-5. PubMed ID: 6375578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune vesicles on the face and neck. A variant of Brunsting-Perry type localized bullous pemphigoid?
    Sugita Y; Inomata N; Takahashi Y; Yomoda M; Hashimoto T; Ikezawa Z
    Eur J Dermatol; 2001; 11(6):557-9. PubMed ID: 11701408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular pemphigoid.
    Bean SF; Michel B; Furey N; Thorne G; Meltzer L
    Arch Dermatol; 1976 Oct; 112(10):1402-4. PubMed ID: 786176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic pemphigoid.
    Honeyman JF; Honeyman AR; De la Parra MA; Pinto A; Eguiguren GJ
    Arch Dermatol; 1979 Apr; 115(4):423-7. PubMed ID: 373638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucous gland basement membrane immunofluorescence in cicatricial pemphigoid.
    Fleming MG; Valenzuela R; Bergfeld WF; Tuthill RJ
    Arch Dermatol; 1988 Sep; 124(9):1407-10. PubMed ID: 3046499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
    White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
    J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3d,g is present in normal human epidermal basement membrane.
    Basset-Seguin N; Dersookian M; Cehrs K; Yancey KB
    J Immunol; 1988 Aug; 141(4):1273-80. PubMed ID: 3135326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.